In March 2021, our experienced intellectual property, antitrust, and health care litigation lawyers shared some predictions on antitrust policy and enforcement in the health care sector. In “Health Care Antitrust under...more
10/22/2021
/ Antitrust Provisions ,
Biden Administration ,
Competition ,
Drug Pricing ,
Enforcement ,
Executive Orders ,
Federal Trade Commission (FTC) ,
Generic Drugs ,
Health Care Providers ,
Hospitals ,
Legislative Agendas ,
Mergers ,
Patents ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Physicians ,
Prescription Drugs ,
Presidential Appointments ,
Regulatory Agenda ,
Relief Measures ,
Rulemaking Process ,
Section 2 ,
Sherman Act ,
Webinars